Australia outlines roles and duties of IVD sponsors and manufacturers
This article was originally published in Clinica
Executive Summary
Australia's Therapeutic Goods Administration has issued more details on the conformity assessment process under its new in vitro diagnostics regulations that came into force in July last year. Specifically, the TGA has published documents distinguishing between the responsibilities and obligations of IVD sponsors and manufacturers under the new framework.